Raman Sankar, MD, PhD, FAAN, FAES
Prof Raman Sankar, MD, PhD, FAAN, FAES is Emeritus Professor of Neurology and Pediatrics and Emeritus Chief of Pediatric Neurology at the David Geffen School of Medicine at UCLA, and the UCLA Mattel Children's Hospital.
Dr. Sankar obtained his PhD in Medicinal Chemistry from the University of Washington, Seattle, WA and his MD from Tulane Medical School, New Orleans, LA. As such he has strong interest in the pharmacological basis of rational therapeutics and the impact of genetics on the development of new ASMs.
His laboratory research over three decades has focused on the susceptibility of the developing brain to seizure induced injury and reorganization, mechanisms underlying epilepsy associated comorbidities such as depression as well as attention deficit disorders and autism. His clinical research has involved collaborative studies on anti-seizure medications, and multimodal presurgical evaluation of children for epilepsy surgery.
Prof Sankar's bibliography of more than 350 entries includes 165 plus articles in peer-reviewed journals as well as reviews and book chapters. He has co-edited several books on epilepsy. Dr. Sankar has served on numerous NIH review committees as well as those of several foreign organizations and foundations. He has lectured on the topic of epilepsy worldwide. He has served an extended term on the Commission on Neurobiology of the ILAE and has been a co-organizer of the Workshop on the Neurobiology of Epilepsy. He received the Founders Award of the American Epilepsy Society, in recognition of outstanding lifetime achievement in the field of epilepsy, in December of 2018.
Financial relationships
-   
  Attribution:SelfType of financial relationship:ConsultantIneligible company:Ovid TherapeuticsTopic:Epilepsy TherapeuticsDate added:03/06/2025Date updated:03/06/2025
 -   
  Attribution:SelfType of financial relationship:SpeakerIneligible company:UCBTopic:Epilepsy TherapeuticsDate added:03/06/2025Date updated:03/06/2025
 -   
  Attribution:SelfType of financial relationship:SpeakerIneligible company:SK Life ScienceTopic:Epilepsy TherapeuticsDate added:03/06/2025Date updated:03/06/2025
 -   
  Attribution:SelfType of financial relationship:SpeakerIneligible company:Jazz PharmaceuticalsTopic:Epilepsy TherapeuticsDate added:03/06/2025Date updated:03/06/2025
 -   
  Attribution:SelfType of financial relationship:SpeakerIneligible company:NeurelisTopic:Epilepsy TherapeuticsDate added:03/06/2025Date updated:03/06/2025
 -   
  Attribution:SelfType of financial relationship:Other Professional ServiceIneligible company:BiohavenTopic:DSMBDate added:03/06/2025Date updated:03/06/2025
 -   
  Attribution:SelfType of financial relationship:Other Professional ServiceIneligible company:Vertex PharmaceuticalsTopic:DSMBDate added:03/06/2025Date updated:03/06/2025
 

 Facebook
 X
 LinkedIn
 Forward